Document is current
Any future updates will be listed below
-
Authors
España-Cueto, Sergio https://orcid.org/0000-0002-3026-132X
Loste, Cora
Lladós, Gemma
López, Cristina
Santos, José Ramón
Dulsat, Gemma
García, Anna
Carmezim, João
Carabia, Julia
Ancochea, Águeda
Fernández-Prendres, Carla
Morales-Indiano, Cristian
Quirant, Bibiana
Martínez-Cáceres, Eva
Sanchez, Anna
Parraga, Ivonne Graciela https://orcid.org/0009-0007-1492-7463
Chamorro, Anna
San José, Alba
Abad, Elena
Muñoz-Moreno, Jose A.
Prats, Anna
Fumaz, Carmina R.
Coll-Fernández, Roser
Estany, Carla
Torrano, Pamela
Puig, Jordi
Clotet, Bonaventura https://orcid.org/0000-0003-3232-4598
Tebé, Cristian
Massanella, Marta https://orcid.org/0000-0002-3326-151X
Paredes, Roger https://orcid.org/0000-0002-6553-691X
Mateu, Lourdes https://orcid.org/0000-0001-7223-7611
- License Information
-
More Information
Article History
Received: 17 July 2024
Accepted: 13 February 2025
First Online: 24 February 2025
Competing interests
: LM has received honoraria as speaker from Astra-Zeneca, Gilead, Shionogui and Pfizer, and has participated in advisory boards for Gilead and MSD. CL has received support for attending meetings from Gilead. AG has received grants from Grifols, honoraria for lectures or presentations from Astra-Zeneca, Gilead, and Pfizer and has participated on DSMB or advisory boards for Gilead and MSD. RP hasparticipated in advisory boards for Pfizer, Gilead, MSD, GSK, Atea, Lilly, Roche, Astra-Zeneca, ViiV Healthcare and Theratechnologies, has participated in lectures and seminars funded by Gilead, Pfizer,GSK and AstraZeneca, and has received research funds awarded to his institution from Gilead, Pfizer and MSD. MM has received honoraria for participating in lectures and seminars funded by Gilead, not related to this project.
